Omnivium Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OMNIVIUM PHARMS, and when can generic versions of OMNIVIUM PHARMS drugs launch?
OMNIVIUM PHARMS has six approved drugs.
There are eleven US patents protecting OMNIVIUM PHARMS drugs.
Summary for Omnivium Pharms
| US Patents: | 11 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 6 |
Drugs and US Patents for Omnivium Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omnivium Pharms | NUMBRINO | cocaine hydrochloride | SOLUTION;NASAL | 209575-001 | Jan 10, 2020 | RX | Yes | Yes | 9,867,815 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Omnivium Pharms | ISONIAZID | isoniazid | TABLET;ORAL | 040090-002 | Jun 26, 1997 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Omnivium Pharms | GLYCOPYRROLATE | glycopyrrolate | INJECTABLE;INJECTION | 212871-001 | Nov 29, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Omnivium Pharms | MONOKET | isosorbide mononitrate | TABLET;ORAL | 020215-001 | Jun 30, 1993 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
